Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population
Our findings highlight the baseline characteristics of our patient population and their impact on the outcomes of induction therapy. Unfit patients who received intensive chemotherapy had higher induction mortality and lower overall survival.
Authors
- Hasmukh Jain (ORCID: https://orcid.org/0000-0002-9947-7065)
- Lingaraj Nayak (ORCID: https://orcid.org/0000-0001-9520-795X)
- Alok Shetty (ORCID: https://orcid.org/0000-0001-5423-9832)
- Bhausaheb Bagal (ORCID: https://orcid.org/0000-0001-9754-0182)
- Manju Sengar (ORCID: https://orcid.org/0000-0002-3509-5682)
- Thomas Eipe (ORCID: https://orcid.org/0000-0001-9004-1233)
- Akash Pawar (ORCID: https://orcid.org/0000-0003-0797-8098)
- Neha Sharma (ORCID: https://orcid.org/0000-0002-5540-0509)
Institutions
- Tata Memorial Hospital (IN)
- Advanced Centre for Treatment, Research and Education in Cancer (IN)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1200/go-24-00482
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77